INVESTOR NEWS

Feb 17, 2022

Fourth quarter and full year 2021 report

Moss, 17 February 2021 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..

Feb 11, 2022

Invitation to presentation of 2021 fourth quarter results

Gentian Diagnostics ASA will present its 2021 fourth quarter results on February 17th at 10.00 am. The..

Jan 31, 2022

Global GCAL® distribution contract with Siemens Healthineers

Moss, 31 January 2022 Reference to the stock exchange release dated 5 October 2021 and the 3rd quarter report..

Dec 17, 2021

Financial calendar

Financial calendar for Gentian Diagnostics ASA

Dec 16, 2021

Completed development of SARS CoV-2 antibody assay

Moss, 16 December 2021 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of innovative and..

Dec 10, 2021

Share capital increase registered - Correction*

Moss, 9 December 2021 Reference is made to the stock exchange notice from Gentian Diagnostics ASA (the..

Dec 09, 2021

Share capital increase registered

Moss, 9 December 2021 Reference is made to the stock exchange notice from Gentian Diagnostics ASA (the..